Phillip Wong

23.7k total citations · 2 hit papers
91 papers, 5.4k citations indexed

About

Phillip Wong is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Phillip Wong has authored 91 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 31 papers in Immunology and 25 papers in Molecular Biology. Recurrent topics in Phillip Wong's work include Cancer Immunotherapy and Biomarkers (26 papers), Immunotherapy and Immune Responses (22 papers) and Immune Cell Function and Interaction (13 papers). Phillip Wong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (26 papers), Immunotherapy and Immune Responses (22 papers) and Immune Cell Function and Interaction (13 papers). Phillip Wong collaborates with scholars based in United States, United Kingdom and Australia. Phillip Wong's co-authors include Eric G. Pamer, Clifford J. Steer, Alexander Y. Rudensky, Betsy T. Kren, Fidel Zavala, Kyung Ae Ko, Dan R. Littman, Richard A. Lang, Tim Sparwasser and Derya Unutmaz and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Phillip Wong

85 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens

2002 1.4k citations Steffen Jung, Derya Unutmaz et al. Immunity profile →
Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus

1998 560 citations Phillip Wong, Alexander Y. Rudensky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Wong United States	31	3.2k	1.5k	1.3k	555	513	91	5.4k
Fernando Bazán France	20	3.9k 1.2×	1.5k 1.1×	1.4k 1.1×	429 0.8×	556 1.1×	68	6.7k
Mikael C. I. Karlsson Sweden	39	3.4k 1.1×	1.9k 1.3×	1.1k 0.8×	593 1.1×	295 0.6×	104	5.4k
Maria Raffaella Zocchi Italy	45	3.8k 1.2×	1.6k 1.1×	1.4k 1.1×	350 0.6×	321 0.6×	152	6.0k
Andreas Krueger Germany	41	2.4k 0.7×	2.4k 1.6×	961 0.7×	714 1.3×	644 1.3×	106	5.6k
Larry Kane United States	44	4.5k 1.4×	2.4k 1.6×	2.2k 1.7×	761 1.4×	429 0.8×	96	6.8k
Geert Raes Belgium	44	3.5k 1.1×	1.8k 1.3×	1.6k 1.2×	298 0.5×	802 1.6×	106	6.3k
Masaki Terabe United States	42	4.7k 1.5×	1.6k 1.1×	2.4k 1.8×	459 0.8×	650 1.3×	101	6.5k
Masoud H. Manjili United States	35	2.6k 0.8×	1.7k 1.2×	2.2k 1.7×	561 1.0×	354 0.7×	124	4.7k
Brian T. Edelson United States	36	5.3k 1.7×	1.8k 1.2×	1.1k 0.9×	424 0.8×	689 1.3×	59	7.1k
Pablo Sarobe Spain	39	2.6k 0.8×	1.5k 1.1×	2.0k 1.5×	525 0.9×	935 1.8×	125	5.5k

Countries citing papers authored by Phillip Wong

Since Specialization

Citations

This map shows the geographic impact of Phillip Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Wong more than expected).

Fields of papers citing papers by Phillip Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Wong. The network helps show where Phillip Wong may publish in the future.

Co-authorship network of co-authors of Phillip Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Wong. A scholar is included among the top collaborators of Phillip Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Wong. Phillip Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Autio, Karen A., Deaglan Joseph McHugh, Dana E. Rathkopf, et al.. (2025). Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer. PubMed. 8(2). 172–176. 1 indexed citations

Moore, Zachary, Xiaojing Huang, Stephanie Lobaugh, et al.. (2024). Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis. Radiotherapy and Oncology. 196. 110320–110320.

Gupta, Aditi, Karissa Whiting, Niamh M. Keegan, et al.. (2024). Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO).. Journal of Clinical Oncology. 42(16_suppl). 4569–4569.

Chapman, Paul B., Mark Klang, Michael A. Postow, et al.. (2023). Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib. Cancer Research Communications. 3(12). 2447–2454. 4 indexed citations

Manning‐Geist, Beryl, Sacha Gnjatic, Carol Aghajanian, et al.. (2023). Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission. Cancers. 15(5). 1458–1458. 12 indexed citations

Page, David B., Kathryn Beal, Stefanie N. Linch, et al.. (2022). Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases. npj Breast Cancer. 8(1). 50–50. 25 indexed citations

Paik, Paul K., Jia Luo, Ni Ai, et al.. (2022). Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature Communications. 13(1). 6095–6095. 13 indexed citations

Davar, Diwakar, Roberta Zappasodi, Hong Wang, et al.. (2022). Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors. Clinical Cancer Research. 28(18). 3990–4002. 37 indexed citations

Ladner, Katherine J., Phillip Wong, Murat Baday, et al.. (2022). TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy Images. Cancers. 14(19). 4958–4958. 5 indexed citations

10.

Desir, Snider, Phillip Wong, Thomas J. Turbyville, et al.. (2019). Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells. Cancers. 11(7). 892–892. 49 indexed citations

11.

Martens, Alexander, Kilian Wistuba‐Hamprecht, Jianda Yuan, et al.. (2016). Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab. Clinical Cancer Research. 22(19). 4848–4858. 141 indexed citations

12.

Kitano, Shigehisa, Michael A. Postow, Carly G.K. Ziegler, et al.. (2014). Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes. Cancer Immunology Research. 2(8). 812–821. 111 indexed citations

13.

Beers, Courtney, et al.. (2005). Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo. The Journal of Immunology. 174(3). 1205–1212. 94 indexed citations

14.

Wong, Phillip, María Lara‐Tejero, Alexander Ploß, Ingrid M. Leiner, & Eric G. Pamer. (2004). Rapid Development of T Cell Memory. The Journal of Immunology. 172(12). 7239–7245. 47 indexed citations

15.

Wong, Phillip & Eric G. Pamer. (2004). Disparate In Vitro and In Vivo Requirements for IL-2 During Antigen-Independent CD8 T Cell Expansion. The Journal of Immunology. 172(4). 2171–2176. 29 indexed citations

16.

Wong, Phillip. (2003). Hypokalemic thyrotoxic periodic paralysis: a case series. Canadian Journal of Emergency Medicine. 5(5). 353–355. 12 indexed citations

17.

Wong, Phillip, et al.. (2002). A cross-sectional survey of bone densitometry in children on long term warfarin therapy.. Blood. 100(11). 1 indexed citations

18.

Jung, Steffen, Derya Unutmaz, Phillip Wong, et al.. (2002). In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens. Immunity. 17(2). 211–220. 1421 indexed citations breakdown →

19.

Wong, Phillip & Eric G. Pamer. (2001). Cutting Edge: Antigen-Independent CD8 T Cell Proliferation. The Journal of Immunology. 166(10). 5864–5868. 218 indexed citations

20.

Wong, Phillip, Ananda W. Goldrath, & Alexander Y. Rudensky. (2000). Competition for Specific Intrathymic Ligands Limits Positive Selection in a TCR Transgenic Model of CD4+ T Cell Development. The Journal of Immunology. 164(12). 6252–6259. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact